Printer Friendly

DEL LABORATORIES COMPLETES DEBT REFINANCING

 FARMINGDALE, N.Y., June 4 /PRNewswire/ -- Del Laboratories, Inc. (AMEX: DLI) announced today that it has completed a refinancing of its principal long-term debt. The refinancing involved $40 million, with interest at 9.50 percent per annum, to be repaid in five annual installments of $8 million each, beginning in the year 2001. The new financing replaces indebtedness of $35 million bearing interest at 11.04 percent per annum, which would have required six annual principal payments during 1993 through 1998. Proceeds of the new financing were used to repay the prior loan, a one-time required prepayment charge of $3,850,000 before taxes, and transaction expenses. The balance was added to working capital.
 Del Laboratories, Inc., under its brand trademarks, manufactures and markets Sally Hansen "Hard as Nails" nail care products, America's number one nail protection; Quencher cosmetics; Flame Glow and Natural Glow cosmetics; Rejuvia beauty care products; Nutri-Tonic hair care products; La Cross nail and beauty implements; Naturistics personal care products; Schiaparelli Fragrances and "Auro," "Tanac," "Orajel," "Propa P.H.," "Dermarest," "Pronto," "Diaper-Guard," "Stye," "Triptone," "Arthricare" and other proprietary pharmaceuticals.
 -0- 6/4/93
 /CONTACT: Dan K. Wassong, chairman, president and chief executive officer, or Melvyn C. Goldstein, vice president of finance of Del Laboratories, Inc., 516-293-7070/
 (DLI)


CO: Del Laboratories, Inc. ST: New York IN: HOU SU:

WB-OS -- NY030 -- 5424 06/04/93 12:03 EDT
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jun 4, 1993
Words:229
Previous Article:PIPER JAFFRAY INCOME INDEX
Next Article:BREAKTHROUGH IN CANCER DIAGNOSTICS TOPIC AT MAJOR MEDICAL MEETING OF THE SOCIETY OF NUCLEAR MEDICINE JUNE 8-11
Topics:


Related Articles
DEL LABORATORIES, INC. REPORTS RESULTS
DEL LABORATORIES, INC., DECLARES DIVIDEND
DEL LABORATORIES, INC. REPORTS RESULTS
DEL LABORATORIES REPORTS RESULTS FOR SECOND QUARTER AND FIRST SIX MONTHS OF 1994
DEL LABORATORIES REPORTS RESULTS FOR THE THIRD QUARTER AND NINE MONTHS ENDED SEPT. 30, 1994
DEL LABORATORIES, INC. REPORTS RESULTS FOR YEAR, FOURTH QUARTER
Del Laboratories, Inc. Opens North Carolina Distribution Facility
Del Laboratories Inc. to be Acquired in $465 Million Transaction.
Del Laboratories, Inc. Provides Update On Planned Acquisition by DLI Holding Corp.
Coty Inc. and Del Laboratories, Inc. Announce Acquisition of Del Laboratories, Inc. by Coty Inc.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters